Peter Kopp

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


207 publications

2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | ...
2024
 
Patients' Persistent Symptoms, Clinician Demographics, and Geo-Economic Factors Are Associated with Choice of Therapy for Hypothyroidism by European Thyroid Specialists: The "THESIS" Collaboration.
Attanasio R., Žarković M., Papini E., Nagy E.V., Negro R., Perros P., Akarsu E., Alevizaki M., Ayvaz G., Bednarczuk T. et al., 2024/04. Thyroid, 34 (4) pp. 429-441. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F1A3BEA3CA70]
2023
 
The American Thyroid Association 1923-2023: Honoring Our Past, Embracing Our Future.
Cooper D.S., Kopp P.A., 2023/09. Thyroid, 33 (9) pp. 1005-1010. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F9E698F9E3B4]
Predictive value of multiple variable models including nutritional risk score (NRS 2002) on mortality and length of stay of patients with covid-19 infections. The INCOVO study.
Fatemeh G., Fotsing G., Marques-Vidal P., Kopp P., Barigou M., 2023/06. Clinical nutrition ESPEN, 55 pp. 357-363. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_8C36AA3269FD]
 
Emerging Imaging Technologies for Parathyroid Gland Identification and Vascular Assessment in Thyroid Surgery: A Review From the American Head and Neck Society Endocrine Surgery Section.
Silver Karcioglu A.L., Triponez F., Solórzano C.C., Iwata A.J., Abdelhamid Ahmed A.H., Almquist M., Angelos P., Benmiloud F., Berber E., Bergenfelz A. et al., 2023/03/01. JAMA otolaryngology-- head & neck surgery, 149 (3) pp. 253-260. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_03978E6937BA]
Iodine in the Therapy of Graves' Disease: A Century After Henry S. Plummer.
Kopp P.A., 2023/03. Thyroid, 33 (3) pp. 273-275. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6B70D4B0D8A1]
 
Characteristics of specialists treating hypothyroid patients: the "THESIS" collaborative.
Žarković M., Attanasio R., Nagy E.V., Negro R., Papini E., Perros P., Cohen C.A., Akarsu E., Alevizaki M., Ayvaz G. et al., 2023. Frontiers in endocrinology, 14 p. 1225202. Peer-reviewed.
[DOI][Pmid][serval:BIB_27E8A9C70209]
2022
 
Consumptive hypothyroidism in a patient with malignant rhabdoid tumor of the kidney: case report on a newly found association.
Fiore R., La Rosa S., Uccella S., Marchiori D., Kopp P.A., 2022/10/01. European thyroid journal, 11 (5). Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_30C6132D130A]
 
Is there a role for diagnostic scans in the management of intermediate-risk thyroid cancer?
Danilovic DLS, Coura-Filho G.B., Recchia G.M., Castroneves L.A., Marui S., Buchpiguel C.A., Hoff A.O., Kopp P., 2022/08/01. Endocrine-related cancer, 29 (8) pp. 475-483. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_423E5F64F66F]
 
Thyroid and Breast Cancer in 2 Sisters With Monoallelic Mutations in the Ataxia Telangiectasia Mutated (ATM) Gene.
Miasaki F.Y., Saito K.C., Yamamoto G.L., Boguszewski C.L., de Carvalho G.A., Kimura E.T., Kopp P.A., 2022/04/01. Journal of the Endocrine Society, 6 (4) pp. bvac026. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_01841647FB1B]
 
What's in a Name? A Cost-Effectiveness Analysis of the Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features' Nomenclature Revision.
Mehta V., Naraparaju A., Liao D., Davies L., Haugen B.R., Kopp P.A., Mandel S.J., Nikiforov Y.E., Ross D.S., Shin J.J. et al., 2022/04. Thyroid, 32 (4) pp. 421-428. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_30C6C63CC4F3]
 
Iodine content of frequently used prenatal and adult multivitamins in Switzerland.
Gfeller M., Colque G., Kopp P.A., 2022. Frontiers in endocrinology, 13 p. 1041232. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_37B26EA76DA1]
2021
Papillary Thyroid Carcinoma with Desmoid-Type Fibromatosis: Review of Published Cases.
Roukain A., La Rosa S., Bongiovanni M., Nicod Lalonde M., Cristina V., Montemurro M., Cochet S., Luquain A., Kopp P.A., Sykiotis G.P., 2021/09/06. Cancers, 13 (17) p. 4482. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E774E4C20ED0]
 
Prevalence of Iodine-Induced Hyperthyroidism After Administration of Iodinated Contrast During Radiographic Procedures: A Systematic Review and Meta-Analysis of the Literature.
Bervini S., Trelle S., Kopp P., Stettler C., Trepp R., 2021/07. Thyroid, 31 (7) pp. 1020-1029. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CFA0F90E9BF0]
A Protocol for Rehabilitating the Bypassed Limb Prior to Reversal of Jejunoileal Bypass.
Santini S., Suter M., Martinho-Grueber M., Chaubert C.M., Barigou M., Favre L., Kopp P., Kouadio A., 2021/06. Obesity surgery, 31 (6) pp. 2776-2779. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2428EC64ED10]
Carcinome anaplasique de la thyroïde : nouvelles approches thérapeutiques [Anaplastic thyroid carcinoma : new therapeutic approaches]
Stamatiou A., Herrera-Gómez R.G., Szturz P., Bisig B., Romano E., Sykiotis G., Gorostidi F., La Rosa S., Kopp P., Cristina V., 2021/05/19. Revue medicale suisse, 17 (739) pp. 962-966. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_E0FB351F6891]
 
Challenges in Developing Recommendations Based on Low-Quality Evidence in Thyroid Guidelines.
Sawka A.M., Alexander E.K., Bianco A.C., Chou R., Haugen B.R., Kopp P.A., Pearce E.N., Ross D.S., Smallridge R.C., Jonklaas J., 2021/01. Thyroid, 31 (1) pp. 3-7. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0FC9689678CE]
 
Denosumab for the Treatment of Hypercalcemia in a Patient With Parathyroid Carcinoma: A Case Report.
Roukain A., Alwan H., Bongiovanni M., Sykiotis G.P., Kopp P.A., 2021. Frontiers in endocrinology, 12 p. 794988. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4F4E3D5261F5]
Mice Hypomorphic for Keap1, a Negative Regulator of the Nrf2 Antioxidant Response, Show Age-Dependent Diffuse Goiter with Elevated Thyrotropin Levels.
Ziros P.G., Renaud C.O., Chartoumpekis D.V., Bongiovanni M., Habeos I.G., Liao X.H., Refetoff S., Kopp P.A., Brix K., Sykiotis G.P., 2021/01. Thyroid, 31 (1) pp. 23-35. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_62561B304595]
2020
Incidence trends of lung and gastroenteropancreatic neuroendocrine neoplasms in Switzerland.
Alwan H., La Rosa S., Andreas Kopp P., Germann S., Maspoli-Conconi M., Sempoux C., Bulliard J.L., 2020/12. Cancer medicine, 9 (24) pp. 9454-9461. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_05394D4A81D6]
 
Molecular profile of Hürthle cell carcinomas: recurrent mutations in the Wnt/β-catenin pathway.
Santana N.O., Lerario A.M., Schmerling C.K., Marui S., Alves VAF, Hoff A.O., Kopp P., Danilovic DLS, 2020/12. European journal of endocrinology, 183 (6) pp. 647-656. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DEECA624A73B]
The Transcriptomic Response of the Murine Thyroid Gland to Iodide Overload and the Role of the Nrf2 Antioxidant System.
Chartoumpekis D.V., Ziros P.G., Georgakopoulos-Soares I., Smith AAT, Marques A.C., Ibberson M., A Kopp P., Habeos I., Trougakos I.P., Khoo NKH et al., 2020/09/18. Antioxidants, 9 (9) pp. E884. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F9FB94E92E22]
 
A Survey of American Thyroid Association Members Regarding the 2015 Adult Thyroid Nodule and Differentiated Thyroid Cancer Clinical Practice Guidelines.
Sawka A.M., Gagliardi A.R., Haymart M.R., Sturgeon C., Bernet V., Hoff K., Angelos P., Brito J.P., Haugen B.R., Kim B. et al., 2020/01. Thyroid, 30 (1) pp. 25-33. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D82E9975ADA6]
Hypnosis and superficial cervical anesthesia for total thyroidectomy in a high-risk patient - A case report.
Makovac P., Potié A., Roukain A., Pucci L., Rutz T., Kopp P.A., Matter M., 2020. International journal of surgery case reports, 72 pp. 133-136. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_22F259226345]
 
Retrospective View of Thyroid by Its Former Editors.
Hershman J.M., Davies T.F., Emerson C.H., Kopp P.A., 2020/01. Thyroid, 30 (1) pp. 2-7. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DC4D180E9D28]
 
The heritage of the thyroid: a brief history
Kopp P, 2020. pp. 1-8 dans Werner and Ingbar's the thyroid: a fundamental and clinical text chap. 1, Lippincott, Williams & Wilkins.
[serval:BIB_83434B5615EB]
 
Thyroid hormone synthesis
Kopp P, 2020. pp. 59-85 dans Werner and Ingbar's the thyroid: a fundamental and clinical text chap. 3, Lippincott, Williams & Wilkins.
[serval:BIB_1055D27AC5C3]
 
Werner and Ingbar's the thyroid: a fundamental and clinical text
Braverman LE, Cooper DS, Kopp P (eds.), 2020., Lippincott, Williams & Wilkins.
[serval:BIB_792408104FB9]
2019
 
Thyroid Pathophysiology and Diagnostic Evaluation
Salvatore D, Cohen R, Kopp PA, Larsen PR, 2019/12/06. pp. 332-363 dans Williams Textbook of Endocrinology, Elsevier.
[serval:BIB_5D5A5605D1D6]
 
Farewell Thyroid
Kopp Peter A., 2019/12/01. Thyroid, 29 (12) pp. 1711-1712.
[DOI][WoS][Pmid][serval:BIB_7E6D51B3ADB1]
Impact of non-invasive follicular thyroid neoplasms with papillary-like nuclear features (NIFTP) on risk of malignancy in patients undergoing lobectomy/thyroidectomy for suspected malignancy or malignant fine-needle aspiration cytology findings: a systematic review and meta-analysis.
Bongiovanni M., Faquin W.C., Giovanella L., Durante C., Kopp P., Trimboli P., 2019/10. European journal of endocrinology, 181 (4) pp. 389-396. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_4F7808F63B11]
 
Patient Context and Thyrotropin Levels Are Important When Considering Treatment of Subclinical Hypothyroidism.
Sawka A.M., Cappola A.R., Peeters R.P., Kopp P.A., Bianco A.C., Jonklaas J., 2019/10. Thyroid, 29 (10) pp. 1359-1363. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3FA5BBABBD43]
 
Thoughts on the Japanese and American Perspectives on Thyroid Storm.
Feldt-Rasmussen U., Emerson C.H., Ross D.S., Kopp P.A., Pearce E.N., 2019/08. Thyroid, 29 (8) pp. 1033-1035. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D57D6AC11EE2]
 
Guidelines Are Not Gospel!
Daniels G.H., Kopp P.A., 2019/06. Thyroid, 29 (6) pp. 753-757. Peer-reviewed.
[DOI][Pmid][serval:BIB_47ED492776CF]
 
ECTOPIC ADRENOCORTICOTROPIC HORMONE SYNDROME DUE TO METASTATIC PROSTATE CANCER WITH NEUROENDOCRINE DIFFERENTIATION.
Soundarrajan M., Zelada H., Fischer J.V., Kopp P., 2019. AACE clinical case reports, 5 (3) pp. e192-e196. Peer-reviewed.
[DOI][Pmid][serval:BIB_D4D31F0A4704]
 
Thyroid Hormone Biosynthesis and Physiology
Soundarrajan M, Kopp P, 2019. pp. 1-17 dans Eaton Jennifer L. (eds.) Thyroid Disease and Reproduction: A Clinical Guide to Diagnosis and Management, Springer International Publishing.
[DOI][serval:BIB_3253893A254F]
2018
 
NCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018.
Haddad R.I., Nasr C., Bischoff L., Busaidy N.L., Byrd D., Callender G., Dickson P., Duh Q.Y., Ehya H., Goldner W. et al., 2018/12. Journal of the National Comprehensive Cancer Network, 16 (12) pp. 1429-1440. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B5E270CD6FAF]
 
Thyroid Physiology
Kopp P, 2018/12. pp. 39-50 dans Diagnostic pathology and molecular genetics of the thyroid, Lippincott, Williams and Wilkins.
[serval:BIB_BD1B777F00F4]
 
Das Myxödemherz: The Myxedema Heart Herman Zondek 1887-1979.
Kopp P.A., 2018/09. Thyroid, 28 (9) pp. 1079-1080. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_503AD4D51089]
 
Posterior reversible encephalopathy syndrome and takotsubo cardiomyopathy associated with lenvatinib therapy for thyroid cancer: a case report and review.
Chae Y.K., Chiec L., Adney S.K., Waitzman J., Costa R., Carneiro B., Matsangou M., Agulnik M., Kopp P., Giles F., 2018/06/15. Oncotarget, 9 (46) pp. 28281-28289. Peer-reviewed.
[DOI][Pmid][serval:BIB_F0A96343AA4D]
 
American Thyroid Association Guidelines and Statements: Past, Present, and Future.
Sawka A.M., Carty S.E., Haugen B.R., Hennessey J.V., Kopp P.A., Pearce E.N., Sosa J.A., Tufano R.P., Jonklaas J., 2018/06. Thyroid, 28 (6) pp. 692-706. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_893C63101B94]
 
An Online Survey of Hypothyroid Patients Demonstrates Prominent Dissatisfaction.
Peterson S.J., Cappola A.R., Castro M.R., Dayan C.M., Farwell A.P., Hennessey J.V., Kopp P.A., Ross D.S., Samuels M.H., Sawka A.M. et al., 2018/06. Thyroid, 28 (6) pp. 707-721. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D8EDE0F9AFDF]
 
Release and Decay Kinetics of Copeptin vs AVP in Response to Osmotic Alterations in Healthy Volunteers.
Fenske W.K., Schnyder I., Koch G., Walti C., Pfister M., Kopp P., Fassnacht M., Strauss K., Christ-Crain M., 2018/02/01. The Journal of clinical endocrinology and metabolism, 103 (2) pp. 505-513. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6B5CBB26C054]
 
Heritable and Syndromic Pheochromocytoma and Paraganglioma
Kopp P, 2018. pp. 63-87 dans Landsberg Lewis (eds.) Pheochromocytomas, Paragangliomas and Disorders of the Sympathoadrenal System, Springer International Publishing.
[DOI][serval:BIB_862BD286EBC9]
 
Principles of Endocrine Diseases
Lowden E, Kopp P, 2018. pp. 1-23 dans Belfiore A, LeRoith D (eds.) Endocrinology: Principles of Endocrinology and Hormone Action, Springer.
[serval:BIB_ED414B38610F]
 
Principles of human genetics
Jameson JL, Kopp P, 2018. pp. 3347-3369 dans Harrison's Principles of Internal Medicine, McGraw-Hill.
[serval:BIB_C1D640F2FF00]
2017
 
Pendred syndrome.
Wémeau J.L., Kopp P., 2017/03. Best practice & research. Clinical endocrinology & metabolism, 31 (2) pp. 213-224. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6532C8350EFC]
2016
 
The challenge of developmental therapeutics for adrenocortical carcinoma.
Costa R., Carneiro B.A., Tavora F., Pai S.G., Kaplan J.B., Chae Y.K., Chandra S., Kopp P.A., Giles F.J., 2016/07/19. Oncotarget, 7 (29) pp. 46734-46749. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_11B5DD3C317E]
 
Association of endogenous testosterone with subclinical atherosclerosis in men: the multi-ethnic study of atherosclerosis.
Khazai B., Golden S.H., Colangelo L.A., Swerdloff R., Wang C., Honoris L., Gapstur S.M., Ouyang P., Cushman M., Li D. et al., 2016/05. Clinical endocrinology, 84 (5) pp. 700-707. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3E248804E15F]
 
Plasma Apelin Concentrations in Patients With Polyuria-Polydipsia Syndrome.
Urwyler S.A., Timper K., Fenske W., de Mota N., Blanchard A., Kühn F., Frech N., Arici B., Rutishauser J., Kopp P. et al., 2016/05. The Journal of clinical endocrinology and metabolism, 101 (5) pp. 1917-1923. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_86F2D09CA6BC]
 
Iodide excess regulates its own efflux: a possible involvement of pendrin.
Calil-Silveira J., Serrano-Nascimento C., Kopp P.A., Nunes M.T., 2016/04/01. American journal of physiology. Cell physiology, 310 (7) pp. C576-82. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_44976378D3D3]
 
Genetic forms of neurohypophyseal diabetes insipidus.
Rutishauser J., Spiess M., Kopp P., 2016/03. Best practice & research. Clinical endocrinology & metabolism, 30 (2) pp. 249-262. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F08A88014F7B]
 
Preface - Disturbances of water and electrolyte balance.
Kopp P.A., 2016/03. Best practice & research. Clinical endocrinology & metabolism, 30 (2) pp. 159-160. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1EC89FF1A6EC]
 
Analysis of the PAX8 gene in 32 children with thyroid dysgenesis and functional characterization of a promoter variant.
Perone D., Medeiros-Neto G., Nogueira C.R., Chagas A.J., Alves Dias V.M., Viana M.F., Kopp P., 2016/02. Journal of pediatric endocrinology & metabolism, 29 (2) pp. 193-201. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_76C4D438D9A9]
 
Spotlight on lenvatinib in the treatment of thyroid cancer: patient selection and perspectives.
Costa R., Carneiro B.A., Chandra S., Pai S.G., Chae Y.K., Kaplan J.B., Garrett H.B., Agulnik M., Kopp P.A., Giles F.J., 2016. Drug design, development and therapy, 10 pp. 873-884. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5ED363FD4BB1]
2015
 
Increased expression of the epithelial anion transporter pendrin/SLC26A4 in nasal polyps of patients with chronic rhinosinusitis.
Seshadri S., Lu X., Purkey M.R., Homma T., Choi A.W., Carter R., Suh L., Norton J., Harris K.E., Conley D.B. et al., 2015/12. The Journal of allergy and clinical immunology, 136 (6) pp. 1548-1558.e7. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_017653DA4AAF]
 
Pendrin and anoctamin as mediators of apical iodide efflux in thyroid cells.
Silveira J.C., Kopp P.A., 2015/10. Current opinion in endocrinology, diabetes, and obesity, 22 (5) pp. 374-380. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FC2C23A26805]
 
Squamosal Suture Craniosynostosis Due to Hyperthyroidism Caused by an Activating Thyrotropin Receptor Mutation (T632I).
Chawla R., Alden T.D., Bizhanova A., Kadakia R., Brickman W., Kopp P.A., 2015/10. Thyroid, 25 (10) pp. 1167-1172. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CBE19117807B]
 
Anaplastic Thyroid Carcinoma, Version 2.2015.
Haddad R.I., Lydiatt W.M., Ball D.W., Busaidy N.L., Byrd D., Callender G., Dickson P., Duh Q.Y., Ehya H., Haymart M. et al., 2015/09. Journal of the National Comprehensive Cancer Network, 13 (9) pp. 1140-1150. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A3CD5AB458B5]
 
Targeted therapies in advanced differentiated thyroid cancer.
Carneiro R.M., Carneiro B.A., Agulnik M., Kopp P.A., Giles F.J., 2015/09. Cancer treatment reviews, 41 (8) pp. 690-698. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F34C9602386A]
 
Diagnostic Accuracy of Copeptin in the Differential Diagnosis of the Polyuria-polydipsia Syndrome: A Prospective Multicenter Study.
Timper K., Fenske W., Kühn F., Frech N., Arici B., Rutishauser J., Kopp P., Allolio B., Stettler C., Müller B. et al., 2015/06. The Journal of clinical endocrinology and metabolism, 100 (6) pp. 2268-2274. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5FE8794F4F04]
 
Applications of molecular biology and genetics in endocrinology
Jameson JL, Kopp P, 2015/03/06. pp. 41-67 dans DeGroot LJ, Jameson JL (eds.) Endocrinology, WB Saunders.
[serval:BIB_CE7ABCD2F180]
 
Autonomously functioning thyroid nodules and other causes of thyrotoxicosis
Kopp P, 2015/03/06. pp. 1500-1514 dans DeGroot LJ, Jameson JL (eds.) Endocrinology, WB Saunders.
[serval:BIB_DCBBA33185D4]
 
Principles of human genetics
Jameson JL, Kopp P, 2015. pp. 425-445 dans Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL (eds.) Harrison's Principles of Internal Medicine, McGraw-Hill.
[serval:BIB_EB4AF9F35302]
2014
 
Commentary on: Guidelines for the treatment of hypothyroidism.
Kopp P.A., 2014/12. Thyroid, 24 (12) pp. 1667-1669. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_58AB5AE6EA2B]
 
Thyroid carcinoma, version 2.2014.
Tuttle R.M., Haddad R.I., Ball D.W., Byrd D., Dickson P., Duh Q.Y., Ehya H., Haymart M., Hoh C., Hunt J.P. et al., 2014/12. Journal of the National Comprehensive Cancer Network, 12 (12) pp. 1671-80; quiz 1680. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1E68574CC5E2]
 
Acute myeloid leukemia presenting with panhypopituitarism or diabetes insipidus: a case series with molecular genetic analysis and review of the literature.
Cull E.H., Watts J.M., Tallman M.S., Kopp P., Frattini M., Rapaport F., Rampal R., Levine R., Altman J.K., 2014/09. Leukemia & lymphoma, 55 (9) pp. 2125-2129. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_08DE35A37D61]
 
Classification and proposed nomenclature for inherited defects of thyroid hormone action, cell transport, and metabolism.
Refetoff S., Bassett J.H., Beck-Peccoz P., Bernal J., Brent G., Chatterjee K., De Groot L.J., Dumitrescu A.M., Jameson J.L., Kopp P.A. et al., 2014/03. The Journal of clinical endocrinology and metabolism, 99 (3) pp. 768-770. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_816D5379EDC1]
 
Classification and proposed nomenclature for inherited defects of thyroid hormone action, cell transport, and metabolism.
Refetoff S., Bassett J.H., Beck-Peccoz P., Bernal J., Brent G., Chatterjee K., De Groot L.J., Dumitrescu A.M., Jameson J.L., Kopp P.A. et al., 2014/03. Thyroid, 24 (3) pp. 407-409. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C9D08BAA4562]
 
Classification and proposed nomenclature for inherited defects of thyroid hormone action, cell transport, and metabolism.
Refetoff S., Bassett J.H., Beck-Peccoz P., Bernal J., Brent G., Chatterjee K., De Groot L.J., Dumitrescu A.M., Jameson J.L., Kopp P.A. et al., 2014/03. European thyroid journal, 3 (1) pp. 7-9. Peer-reviewed.
[DOI][Pmid][serval:BIB_E31417C4F08A]
 
Denosumab for management of parathyroid carcinoma-mediated hypercalcemia.
Vellanki P., Lange K., Elaraj D., Kopp P.A., El Muayed M., 2014/02. The Journal of clinical endocrinology and metabolism, 99 (2) pp. 387-390. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F296CF96DFEE]
 
Vitamin D status, functional decline, and mortality in peripheral artery disease.
McDermott M.M., Liu K., Ferrucci L., Tian L., Guralnik J., Kopp P., Van Horn L., Liao Y., Green D., Kibbe M. et al., 2014/02. Vascular medicine, 19 (1) pp. 18-26. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4D1A736970E4]
 
American Thyroid Association Guide to investigating thyroid hormone economy and action in rodent and cell models.
Bianco A.C., Anderson G., Forrest D., Galton V.A., Gereben B., Kim B.W., Kopp P.A., Liao X.H., Obregon M.J., Peeters R.P. et al., 2014/01. Thyroid, 24 (1) pp. 88-168. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0B9CAD6CDDE4]
 
Goitrogenese und ihre Konsequenz für die Schilddrüsenchirurgie
Kurman A, Kopp P, Seiler CA, 2014. pp. 38-49 dans Dralle H (eds.) Schilddrüsenchirurgie: Evidenz und Erfahrung, Schattauer.
[serval:BIB_C4AA4260DE17]
 
Iodide transport: implications for health and disease.
Pesce L., Kopp P., 2014. International journal of pediatric endocrinology, 2014 (1) p. 8. Peer-reviewed.
[DOI][Pmid][serval:BIB_AAF5620C080E]
 
Mutations in the Pendred Syndrome (PDS/SLC26A) gene: an increasingly complex phenotypic spectrum from goiter to thyroid hypoplasia.
Kopp P., 2014/01. The Journal of clinical endocrinology and metabolism, 99 (1) pp. 67-69. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A91022C93CF9]
2013
 
The Launch of the Chinese Version of Thyroid: An Earthshaking Event
Kopp Peter A., 2013/08. Thyroid, 23 (8) pp. 926-926.
[DOI][WoS][Pmid][serval:BIB_E8767EE9AF85]
 
Acute diabetes insipidus mediated by vasopressinase after placental abruption.
Wallia A., Bizhanova A., Huang W., Goldsmith S.L., Gossett D.R., Kopp P., 2013/03. The Journal of clinical endocrinology and metabolism, 98 (3) pp. 881-886. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1ADB55019429]
 
Thyroid hormone synthesis: thyroid iodine metabolism
Kopp P, 2013. pp. 48-74 dans Braverman LE, Cooper DS (eds.) Werner and Ingbar's the thyroid: a fundamental and clinical text, Lippincott, Williams & Wilkins.
[serval:BIB_CC8B2F63A40D]
 
Welcome to a New Year in Thyroid
Kopp Peter, 2013/01. Thyroid, 23 (1) pp. 5-6.
[DOI][WoS][serval:BIB_BA19E4BBBADC]
2012
 
Oncogenic osteomalacia: loss of hypophosphatemia might be the key to avoid misdiagnosis
Chang Claudia V., Conde Sandro J., Luvizotto Renata A. M., Nunes Vânia S., Bonates Milla C., Felicio Andre C., Lindsey Susan C., Moraes Flávia H., Tagliarini José V., Mazeto Glaucia M. F. S. et al., 2012/11. Arquivos Brasileiros de Endocrinologia & Metabologia, 56 (8) pp. 570-573.
[DOI][WoS][Pmid][serval:BIB_C579C63032D0]
 
Vitamin D status and functional performance in peripheral artery disease.
McDermott M.M., Liu K., Ferrucci L., Tian L., Guralnik J., Kopp P., Tao H., Van Horn L., Liao Y., Green D. et al., 2012/10. Vascular medicine, 17 (5) pp. 294-302. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_74A3D8EFA63F]
 
Genetics
Kopp P, Camacho PM, Gharib H, Sizemore GW, 2012. pp. 372-384 dans Evidence-based endocrinology, Lippincott Williams & Wilkins.
[serval:BIB_45B9ADDFB6FA]
 
Thyroid Physiology
Kopp P, 2012. pp. 33-42 dans Nikiforov Y, Biddinger PW, Thompson LDR (eds.) Diagnostic pathology and molecular genetics of the thyroid, Lippincott Williams and Wilkins.
[serval:BIB_EBD1F02677FA]
 
TSH regulates pendrin membrane abundance and enhances iodide efflux in thyroid cells.
Pesce L., Bizhanova A., Caraballo J.C., Westphal W., Butti M.L., Comellas A., Kopp P., 2012/01. Endocrinology, 153 (1) pp. 512-521. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6CF855659755]
2011
 
Variants near FOXE1 are associated with hypothyroidism and other thyroid conditions: using electronic medical records for genome- and phenome-wide studies.
Denny J.C., Crawford D.C., Ritchie M.D., Bielinski S.J., Basford M.A., Bradford Y., Chai H.S., Bastarache L., Zuvich R., Peissig P. et al., 2011/10/07. American journal of human genetics, 89 (4) pp. 529-542. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FDDB0D00989E]
 
Familial forms of diabetes insipidus: clinical and molecular characteristics.
Babey M., Kopp P., Robertson G.L., 2011/07/05. Nature reviews. Endocrinology, 7 (12) pp. 701-714. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B90C65A0EA3B]
 
Primary CNS lymphoma with bilateral symmetric hypothalamic lesions presenting with panhypopituitarism and diabetes insipidus.
Layden B.T., Dubner S., Toft D.J., Kopp P., Grimm S., Molitch M.E., 2011/06. Pituitary, 14 (2) pp. 194-197. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CB2B295589B9]
 
cDNA immunization of mice with human thyroglobulin generates both humoral and T cell responses: a novel model of thyroid autoimmunity.
Jacobson E.M., Concepcion E., Ho K., Kopp P., Vono Toniolo J., Tomer Y., 2011/04/29. PloS one, 6 (4) pp. e19200. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D22FFDC8F163]
 
Clinical and molecular characteristics of Pendred syndrome.
Kopp P., Bizhanova A., 2011/04. Annales d'endocrinologie, 72 (2) pp. 88-94. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C0C5C9050C0D]
 
Correlation of plasma copeptin and vasopressin concentrations in hypo-, iso-, and hyperosmolar States.
Balanescu S., Kopp P., Gaskill M.B., Morgenthaler N.G., Schindler C., Rutishauser J., 2011/04. The Journal of clinical endocrinology and metabolism, 96 (4) pp. 1046-1052. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_32FC818AB0E4]
 
Analysis of cellular localization and function of carboxy-terminal mutants of pendrin.
Bizhanova A., Chew T.L., Khuon S., Kopp P., 2011. Cellular physiology and biochemistry, 28 (3) pp. 423-434. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3F7CCF6BE5C5]
 
Controversies concerning the role of pendrin as an apical iodide transporter in thyroid follicular cells.
Bizhanova A., Kopp P., 2011. Cellular physiology and biochemistry, 28 (3) pp. 485-490. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CA5A73C1EF67]
 
Identification of allelic variants of pendrin (SLC26A4) with loss and gain of function.
Dossena S., Bizhanova A., Nofziger C., Bernardinelli E., Ramsauer J., Kopp P., Paulmichl M., 2011. Cellular physiology and biochemistry, 28 (3) pp. 467-476. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_BFF696E006D9]
 
Principles of human genetics
Jameson JL, Kopp P, 2011. pp. 486-509 dans Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL (eds.) Harrison's Principles of Internal Medicine, McGraw-Hill.
[serval:BIB_E446483658CB]
2010
 
Thyroid carcinoma.
Tuttle R.M., Ball D.W., Byrd D., Dilawari R.A., Doherty G.M., Duh Q.Y., Ehya H., Farrar W.B., Haddad R.I., Kandeel F. et al., 2010/11. Journal of the National Comprehensive Cancer Network, 8 (11) pp. 1228-1274. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DA6D984E4C2D]
 
Molekulare Früherkennung in der Endokrinologie - auf dem Weg zur differenzierten Behandlung komplexer Hormon- und Stoffwechselstörungen [Molecular tests for (early) recognition of endocrine disorders - towards a sophisticated management of complex endocrine and metabolic diseases]
Kopp P., 2010/07. Therapeutische Umschau. Revue therapeutique, 67 (7) pp. 367-373. Peer-reviewed.
[DOI][Pmid][serval:BIB_6648CF11C7C7]
 
Genetics and phenomics of Pendred syndrome.
Bizhanova A., Kopp P., 2010/06/30. Molecular and cellular endocrinology, 322 (1-2) pp. 83-90. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_683652A7A5AE]
 
Medullary carcinoma.
Tuttle R.M., Ball D.W., Byrd D., Daniels G.H., Dilawari R.A., Doherty G.M., Duh Q.Y., Ehya H., Farrar W.B., Haddad R.I. et al., 2010/05. Journal of the National Comprehensive Cancer Network, 8 (5) pp. 512-530. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4DF2B3E340A6]
 
A novel mutation in the AVPR2 gene (222delA) associated with X-linked nephrogenic diabetes insipidus in a boy with growth failure.
Abaci A., Wood K., Demir K., Büyükgebiz A., Böber E., Kopp P., 2010. Endocrine practice, 16 (2) pp. 231-236. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_284D847FF7D6]
 
Applications of molecular biology and genetics in endocrinology
Jameson JL, Kopp P, 2010. pp. 118-143 dans DeGroot LJ, Jameson JL (eds.) Endocrinology, WB Saunders.
[serval:BIB_6980BFD5D254]
 
Molecular analysis of the PROP1 and HESX1 genes in patients with septo-optic dysplasia and/or pituitary hormone deficiency.
Cruz J.B., Nunes V.S., Clara S.A., Perone D., Kopp P., Nogueira C.R., 2010. Arquivos brasileiros de endocrinologia e metabologia, 54 (5) pp. 482-487. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A798727BB3F3]
 
Thyrotoxicosis of other etiologies
Kopp P, 2010. dans Thyroid Disease Manager - Endotext, www.thyroidmanager.org.
[serval:BIB_C00A899BDCB0]
2009
 
Theodor Kocher (1841-1917) Nobel prize centenary 2009.
Kopp P., 2009/12. Arquivos brasileiros de endocrinologia e metabologia, 53 (9) pp. 1176-1180. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FF6E330FE9C2]
 
Serum IGF-I and C-reactive protein in healthy black and white young men: the CARDIA male hormone study.
Colangelo L.A., Chiu B., Kopp P., Liu K., Gapstur S.M., 2009/10. Growth hormone & IGF research, 19 (5) pp. 420-425. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0C0CFFF504E3]
 
The p.A2215D thyroglobulin gene mutation leads to deficient synthesis and secretion of the mutated protein and congenital hypothyroidism with wide phenotype variation.
Pardo V., Vono-Toniolo J., Rubio I.G., Knobel M., Possato R.F., Targovnik H.M., Kopp P., Medeiros-Neto G., 2009/08. The Journal of clinical endocrinology and metabolism, 94 (8) pp. 2938-2944. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7C39092B4289]
 
Association of endogenous sex hormones with diabetes and impaired fasting glucose in men: multi-ethnic study of atherosclerosis.
Colangelo L.A., Ouyang P., Liu K., Kopp P., Golden S.H., Dobs A.S., Szklo M., Vaidya D., Cushman M., Gapstur S.M., 2009/06. Diabetes care, 32 (6) pp. 1049-1051. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9BAEA12F37E3]
 
Sex hormone levels and subclinical atherosclerosis in postmenopausal women: the Multi-Ethnic Study of Atherosclerosis.
Ouyang P., Vaidya D., Dobs A., Golden S.H., Szklo M., Heckbert S.R., Kopp P., Gapstur S.M., 2009/05. Atherosclerosis, 204 (1) pp. 255-261. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B40ECC585D8B]
 
Minireview: The sodium-iodide symporter NIS and pendrin in iodide homeostasis of the thyroid.
Bizhanova A., Kopp P., 2009/03. Endocrinology, 150 (3) pp. 1084-1090. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0ECA436B5712]
 
Genetics and genomics
Kopp P, 2009. pp. 1-23 dans Brook GD, Brown R (eds.) Clinical Pediatric Endocrinology, Blackwell Science.
[serval:BIB_3D1753D8E40F]
 
Pendred’s syndrome
Forrest D, Kopp P, 2009. pp. 1600-1603 dans Lange R (eds.) Encyclopedia of Molecular Mechanisms of Disease, Springer.
[serval:BIB_BE3586034744]
 
Pendred’s syndrome: deficiency in iodide transport
Kopp P, Schnyder S, Pesce L, 2009. pp. 231-241 dans Preedy VR, Burrow GN, Watson RR (eds.) The Comprehensive Handbook on Iodide, Elsevier.
[serval:BIB_8E6DB05B913E]
 
Primärer und hereditärer Hyperparathyroidismus
Babey M, Kopp P, 2009. Swiss Medical Forum, 9 pp. 791-797.
[serval:BIB_1E97A89B796C]
 
Thyroid hormone synthesis
Kopp P, Solis-S JC, 2009. pp. 19-41 dans Wondisford FE, Radovick S (eds.) Clinical management of thyroid disease, Saunders-Elsevier.
[serval:BIB_377F14E571CD]
 
Thyroid hormone-dependent hearing loss
Forrest D, Kopp P, 2009. pp. 2073-2075 dans Lange R (eds.) Encyclopedia of Molecular Mechanisms of Disease, Springer.
[serval:BIB_EAF0CFEF0A27]
 
Thyroid Physiology
Kopp P, 2009. pp. 29-38 dans Nikiforov Y, Biddinger PW, Thompson LDR (eds.) Diagnostic pathology and molecular genetics of the thyroid, Lippincott Williams and Wilkins.
[serval:BIB_A647CA593A53]
2008
 
Pendred syndrome and iodide transport in the thyroid.
Kopp P., Pesce L., Solis-S J.C., 2008/09. Trends in endocrinology and metabolism, 19 (7) pp. 260-268. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FA6BD1A234F7]
 
Reduce, recycle, reuse--iodotyrosine deiodinase in thyroid iodide metabolism.
Kopp P.A., 2008/04/24. The New England journal of medicine, 358 (17) pp. 1856-1859. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E251757EC7B8]
 
Associations of serum sex hormone binding globulin (SHBG) levels with SHBG gene polymorphisms in the CARDIA Male Hormone Study.
Turk A., Kopp P., Colangelo L.A., Urbanek M., Wood K., Liu K., Skinner H.G., Gapstur S.M., 2008/02/15. American journal of epidemiology, 167 (4) pp. 412-418. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_EC09EBE77FF9]
 
Principles of human genetics
Jameson JL, Kopp P, 2008. pp. 385-406 dans Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL (eds.) Harrison's Principles of Internal Medicine, McGraw-Hill.
[serval:BIB_A2490420FDD4]
2007
 
Molecular analysis of the Von Hippel-Lindau (VHL) gene in a family with non-syndromic pheochromocytoma: the importance of genetic testing.
Cruz J.B., Fernandes L.P., Clara S.A., Conde S.J., Perone D., Kopp P., Nogueira C.R., 2007/12. Arquivos brasileiros de endocrinologia e metabologia, 51 (9) pp. 1463-1467. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FFE101FD9DED]
 
Applications of molecular biology and genetics in endocrinology.
Kopp P., 2007/09. Endocrine practice, 13 (5) pp. 534-541. Peer-reviewed.
[DOI][Pmid][serval:BIB_8C6061C11D88]
 
Thyroid carcinoma.
Sherman S.I., Angelos P., Ball D.W., Byrd D., Clark O.H., Daniels G.H., Dilawari R.A., Ehya H., Farrar W.B., Gagel R.F. et al., 2007/07. Journal of the National Comprehensive Cancer Network, 5 (6) pp. 568-621. Peer-reviewed.
[DOI][Pmid][serval:BIB_28F433493D91]
 
Changes in BMI modulate age-associated changes in sex hormone binding globulin and total testosterone, but not bioavailable testosterone in young adult men: the CARDIA Male Hormone Study.
Gapstur S.M., Kopp P., Gann P.H., Chiu B.C., Colangelo L.A., Liu K., 2007/04. International journal of obesity, 31 (4) pp. 685-691. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_716A14FAD44D]
 
Endogenous sex hormones and glucose tolerance status in postmenopausal women.
Golden S.H., Dobs A.S., Vaidya D., Szklo M., Gapstur S., Kopp P., Liu K., Ouyang P., 2007/04. The Journal of clinical endocrinology and metabolism, 92 (4) pp. 1289-1295. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B564BBEB5B08]
 
Total testosterone, androgen receptor polymorphism, and depressive symptoms in young black and white men: the CARDIA Male Hormone Study.
Colangelo L.A., Sharp L., Kopp P., Scholtens D., Chiu B.C., Liu K., Gapstur S.M., 2007. Psychoneuroendocrinology, 32 (8-10) pp. 951-958. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1B9F2860E725]
2006
 
Goitrous congenital hypothyroidism and hearing impairment associated with mutations in the TPO and SLC26A4/PDS genes.
Pfarr N., Borck G., Turk A., Napiontek U., Keilmann A., Müller-Forell W., Kopp P., Pohlenz J., 2006/07. The Journal of clinical endocrinology and metabolism, 91 (7) pp. 2678-2681. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9C640F69BEF9]
 
Applications of molecular biology and genetics in endocrinology
Jameson JL, Kopp P, 2006. pp. 83-108 dans DeGroot LJ, Jameson JL (eds.) Endocrinology, WB Saunders.
[serval:BIB_AA50081E57C3]
 
Genetic basis of thyroid disorders
Kopp P, 2006. pp. 1862-1867 dans Ganten D, Ruekpaul K (eds.) Genomics and proteomics in molecular medicine, Springer.
[serval:BIB_51FCA7B17E25]
 
Genetics
Kopp P, 2006. pp. 261-276 dans Camacho PM, Gharib H, Sizemore GW (eds.) Evidence-based endocrinology, Lippincott Williams & Wilkins.
[serval:BIB_AEC790024603]
 
Hyperthyroidism in pregnancy
Wagh A, Kopp P, 2006. dans Physicians' Information and Education Resource (PIER), American College of Physicians.
[serval:BIB_9C831BDE0F2C]
 
Thyroid disorders
Kopp P, Runge MS, Patterson WC, 2006. pp. 337-356 dans Principles of Molecular Medicine, Humana Press.
[serval:BIB_D0EF8DC139D3]
2005
 
Naturally occurring mutations in the thyroglobulin gene.
Vono-Toniolo J., Rivolta C.M., Targovnik H.M., Medeiros-Neto G., Kopp P., 2005/09. Thyroid, 15 (9) pp. 1021-1033. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F579CA971D6D]
 
Molecular analysis of the PDS gene in a nonconsanguineous Sicilian family with Pendred's syndrome.
Gillam M.P., Bartolone L., Kopp P., Benvenga S., 2005/07. Thyroid, 15 (7) pp. 734-741. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3AEAF1705F56]
 
Thyroid carcinoma.
Sherman S.I., Angelos P., Ball D.W., Beenken S.W., Byrd D., Clark O.H., Daniels G.H., Dilawari R.A., Ehya H., Farrar W.B. et al., 2005/05. Journal of the National Comprehensive Cancer Network, 3 (3) pp. 404-457. Peer-reviewed.
[DOI][Pmid][serval:BIB_FD9B555E6B76]
 
Quantitative trait loci associated with elevated thyroid-stimulating hormone in the Wistar-Kyoto rat.
Baum A.E., Solberg L.C., Kopp P., Ahmadiyeh N., Churchill G., Takahashi J.S., Jameson J.L., Redei E.E., 2005/02. Endocrinology, 146 (2) pp. 870-878. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F0D7E2987410]
 
Genetics, genomics, proteomics, and bioinformatics
Kopp P, 2005. pp. 18-44 dans Brook GD, Clayton PE, Brown RS (eds.) Clinical Pediatric Endocrinology, Blackwell Science.
[serval:BIB_76C998594482]
 
IGF-1, IGFBP-3, and nutritional factors in young black and white men: the CARDIA Male Hormone Study.
Colangelo L.A., Chiu B.C., Liu K., Kopp P.A., Gann P.H., Gapstur S.M., 2005. Nutrition and cancer, 53 (1) pp. 57-64. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_324524DC9CF7]
 
Thyroid hormone synthesis: thyroid iodine metabolism
Kopp P, 2005. pp. 52-76 dans Braverman LE, Utiger RD (eds.) Werner and Ingbar's the thyroid: a fundamental and clinical text, Lippincott, Williams & Wilkins.
[serval:BIB_A43965FA5EFE]
2004
 
Longitudinal associations of age, anthropometric and lifestyle factors with serum total insulin-like growth factor-I and IGF binding protein-3 levels in Black and White men: the CARDIA Male Hormone Study.
Gapstur S.M., Kopp P., Chiu B.C., Gann P.H., Colangelo L.A., Liu K., 2004/12. Cancer epidemiology, biomarkers & prevention, 13 (12) pp. 2208-2216. Peer-reviewed.
[WoS][Pmid][serval:BIB_F8BC6EB67F60]
 
Functional characterization of pendrin in a polarized cell system. Evidence for pendrin-mediated apical iodide efflux.
Gillam M.P., Sidhaye A.R., Lee E.J., Rutishauser J., Stephan C.W., Kopp P., 2004/03/26. The Journal of biological chemistry, 279 (13) pp. 13004-13010. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_80B3C96E4988]
 
Thyroglobulin gene mutations and other genetic defects associated with congenital hypothyroidism.
Vono-Toniolo J., Kopp P., 2004/02. Arquivos brasileiros de endocrinologia e metabologia, 48 (1) pp. 70-82. Peer-reviewed.
[DOI][Pmid][serval:BIB_02696B1E2401]
 
Principles of human genetics
Jameson JL, Kopp P, 2004. pp. 359-379 dans Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL (eds.) Harrison's Principles of Internal Medicine, McGraw-Hill.
[serval:BIB_CC0CF3531E43]
2003
 
Identification of thyroid hormone receptors in the human larynx.
Altman K.W., Haines G.K., Vakkalanka S.K., Keni S.P., Kopp P.A., Radosevich J.A., 2003/11. The Laryngoscope, 113 (11) pp. 1931-1934. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_50197B492378]
 
Familial combined pituitary hormone deficiency due to a novel mutation R99Q in the hot spot region of Prophet of Pit-1 presenting as constitutional growth delay.
Vieira T.C., Dias da Silva M.R., Cerutti J.M., Brunner E., Borges M., Arnaldi L.T., Kopp P., Abucham J., 2003/01. The Journal of clinical endocrinology and metabolism, 88 (1) pp. 38-44. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A94D1CCA9C98]
 
Men with acquired hypogonadotropic hypogonadism treated with testosterone may be fertile.
Drincic A., Arseven O.K., Sosa E., Mercado M., Kopp P., Molitch M.E., 2003. Pituitary, 6 (1) pp. 5-10. Peer-reviewed.
[DOI][Pmid][serval:BIB_26EDCA508A39]
2002
 
Serum androgen concentrations in young men: a longitudinal analysis of associations with age, obesity, and race. The CARDIA male hormone study.
Gapstur S.M., Gann P.H., Kopp P., Colangelo L., Longcope C., Liu K., 2002/10. Cancer epidemiology, biomarkers & prevention, 11 (10 Pt 1) pp. 1041-1047. Peer-reviewed.
[WoS][Pmid][serval:BIB_F0D74B6945E2]
 
Perspective: genetic defects in the etiology of congenital hypothyroidism.
Kopp P., 2002/06. Endocrinology, 143 (6) pp. 2019-2024. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_91FA39A86C8A]
 
Clinical and molecular analysis of three families with autosomal dominant neurohypophyseal diabetes insipidus associated with a novel and recurrent mutations in the vasopressin-neurophysin II gene.
Rutishauser J., Kopp P., Gaskill M.B., Kotlar T.J., Robertson G.L., 2002/05. European journal of endocrinology, 146 (5) pp. 649-656. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8D9155A1A270]
 
Cloning of the cat TSH receptor and evidence against an autoimmune etiology of feline hyperthyroidism.
Nguyen L.Q., Arseven O.K., Gerber H., Stein B.S., Jameson J.L., Kopp P., 2002/02. Endocrinology, 143 (2) pp. 395-402. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1E2A9F77BDBE]
 
A de novo mutation in the thyroid hormone receptor beta gene in a Brazilian boy with resistance to thyroid hormone
Marui S, Kopp P, Latronico AC, Estefan V, Mendonca BB, 2002. pp. 75-80 dans Tireoide e Paratireoide: Estudo de Casos, Editor Lenine Garcia Bransão. Editora Parma Ltda.
[serval:BIB_2EBA221DBD5F]
2001
 
Aggressive metastatic follicular thyroid carcinoma with anaplastic transformation arising from a long-standing goiter in a patient with Pendred's syndrome.
Camargo R., Limbert E., Gillam M., Henriques M.M., Fernandes C., Catarino A.L., Soares J., Alves V.A., Kopp P., Medeiros-Neto G., 2001/10. Thyroid, 11 (10) pp. 981-988. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E5D21458B1BC]
 
Autosomal dominant neurohypophyseal diabetes insipidus in a Swiss family, caused by a novel mutation (C59Delta/A60W) in the neurophysin moiety of prepro-vasopressin-neurophysin II (AVP-NP II).
Flück C.E., Deladoëy J., Nayak S., Zeller O., Kopp P., Mullis P.E., 2001/10. European journal of endocrinology, 145 (4) pp. 439-444. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_38D18B9DCAA8]
 
Postload plasma glucose concentration and 27-year prostate cancer mortality (United States).
Gapstur S.M., Gann P.H., Colangelo L.A., Barron-Simpson R., Kopp P., Dyer A., Liu K., 2001/10. Cancer causes & control, 12 (8) pp. 763-772. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E2C83E787B30]
 
A novel mutation (Q40P) in PAX8 associated with congenital hypothyroidism and thyroid hypoplasia: evidence for phenotypic variability in mother and child.
Congdon T., Nguyen L.Q., Nogueira C.R., Habiby R.L., Medeiros-Neto G., Kopp P., 2001/08. The Journal of clinical endocrinology and metabolism, 86 (8) pp. 3962-3967. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3D9DF7B4FD2A]
 
Genetic defects in thyroid hormone synthesis.
Gillam M.P., Kopp P., 2001/08. Current opinion in pediatrics, 13 (4) pp. 364-372. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8502CBB1EEEA]
 
Genetic regulation of thyroid development.
Gillam M.P., Kopp P., 2001/08. Current opinion in pediatrics, 13 (4) pp. 358-363. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9C16E53B2625]
 
The TSH receptor and its role in thyroid disease.
Kopp P., 2001/08. Cellular and molecular life sciences, 58 (9) pp. 1301-1322. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F8C32472DE02]
 
Clinical and molecular analysis of three Mexican families with Pendred's syndrome.
Gonzalez Trevino O., Karamanoglu Arseven O., Ceballos C.J., Vives V.I., Ramirez R.C., Gomez V.V., Medeiros-Neto G., Kopp P., 2001/06. European journal of endocrinology, 144 (6) pp. 585-593. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_87C5477EC2F8]
 
Pendrin: an apical Cl-/OH-/HCO3- exchanger in the kidney cortex.
Soleimani M., Greeley T., Petrovic S., Wang Z., Amlal H., Kopp P., Burnham C.E., 2001/02. American journal of physiology. Renal physiology, 280 (2) pp. F356-64. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1B97216D052C]
 
Activating TSH receptor mutations as a cause of thyrotoxicosis
Kopp P, 2001. dans Harrison's Online, McGraw-Hill.
[serval:BIB_310865D497D4]
 
Pendrin and its function in thyrocytes, the kidney and the inner ear
Kopp P, 2001. Hot Thyroidology.
[serval:BIB_04341BA3C9EB]
 
Principles of human genetics
Jameson JL, Kopp P, 2001. pp. 375-396 dans Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL (eds.) Harrison's Principles of Internal Medicine, McGraw-Hill.
[serval:BIB_33F1A0344CEF]
2000
 
A novel mutation (M310L) in the thyroid hormone receptor beta causing resistance to thyroid hormone in a Brazilian kindred and a neonate.
Furlanetto T.W., Kopp P., Peccin S., Gu W.X., Jameson J.L., 2000/11. Molecular genetics and metabolism, 71 (3) pp. 520-526. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7B756D41ADB1]
 
A dominant negative CREB (cAMP response element-binding protein) isoform inhibits thyrocyte growth, thyroid-specific gene expression, differentiation, and function.
Nguyen L.Q., Kopp P., Martinson F., Stanfield K., Roth S.I., Jameson J.L., 2000/09. Molecular endocrinology, 14 (9) pp. 1448-1461. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1D40FFB2F9C7]
 
Combined pituitary hormone deficiency caused by a novel mutation of a highly conserved residue (F88S) in the homeodomain of PROP-1.
Osorio M.G., Kopp P., Marui S., Latronico A.C., Mendonca B.B., Arnhold I.J., 2000/08. The Journal of clinical endocrinology and metabolism, 85 (8) pp. 2779-2785. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B69F35BCFD4A]
 
Pendred's syndrome and genetic defects in thyroid hormone synthesis.
Kopp P., 2000/01. Reviews in endocrine & metabolic disorders, 1 (1-2) pp. 109-121. Peer-reviewed.
[DOI][Pmid][serval:BIB_A840BF8EFE1B]
 
Substitutions of tyrosine 601 in the human thyrotropin receptor result in increase or loss of basal activation of the cyclic adenosine monophosphate pathway and disrupt coupling to Gq/11.
Arseven O.K., Wilkes W.P., Jameson J.L., Kopp P., 2000/01. Thyroid, 10 (1) pp. 3-10. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_BBC613AE2AAC]
 
Thyroid disorders
Kopp P, 2000. pp. 655-673 dans Goldman MB, Hatch MC (eds.) Women and Health, Academic Press.
[serval:BIB_95370922DB74]
1999
 
Thyrotropin receptor mutations in hyperfunctioning thyroid adenomas from Brazil.
Nogueira C.R., Kopp P., Arseven O.K., Santos C.L., Jameson J.L., Medeiros-Neto G., 1999/11. Thyroid, 9 (11) pp. 1063-1068. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_ECB7A5B72E84]
 
Structural analysis of the thyrotropin receptor in four patients with congenital hypothyroidism due to thyroid hypoplasia.
Nogueira C.R., Nguyen L.Q., Coelho-Neto J.R., Arseven O.K., Jameson J.L., Kopp P., Medeiros-Neto G.A., 1999/06. Thyroid, 9 (6) pp. 523-529. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FFE2D4DF6D33]
 
A novel mutation (R97C) in the neurophysin moiety of prepro-vasopressin-neurophysin II associated with autosomal-dominant neurohypophyseal diabetes insipidus.
Rutishauser J., Kopp P., Gaskill M.B., Kotlar T.J., Robertson G.L., 1999/05. Molecular genetics and metabolism, 67 (1) pp. 89-92. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5C0D28AC9CE2]
 
Combined pituitary hormone deficiency in an inbred Brazilian kindred associated with a mutation in the PROP-1 gene.
Nogueira C.R., Sabacan L., Jameson J.L., Medeiros-Neto G., Kopp P., 1999/05. Molecular genetics and metabolism, 67 (1) pp. 58-61. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C444900ACC76]
 
Targeted disruption of the Ahch (Dax-1) gene: knockout of old concepts.
Kopp P., 1999/04. European journal of endocrinology, 140 (4) pp. 291-292. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DA58531D2DFD]
 
Aquaporin-2 water channel mutations and nephrogenic diabetes insipidus: new variations on a theme.
Rutishauser J., Kopp P., 1999/02. European journal of endocrinology, 140 (2) pp. 137-139. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4D2623785337]
 
Expression of transforming growth factor beta1, beta2, and beta3 in multinodular goiters and differentiated thyroid carcinomas: a comparative study.
Kimura E.T., Kopp P., Zbaeren J., Asmis L.M., Ruchti C., Maciel R.M., Studer H., 1999/02. Thyroid, 9 (2) pp. 119-125. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_091FFBF1EAAB]
 
Pendred's syndrome: Clinical characteristics and molecular basis
Kopp P, 1999. Current Opinion in Endocrinology and Diabetes , 6 pp. 261-269.
[serval:BIB_A262DFA78877]
 
Pendred's syndrome: identification of the genetic defect a century after its recognition.
Kopp P., 1999/01. Thyroid, 9 (1) pp. 65-69. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_69ECBD9978F8]
 
Phenocopies for deafness and goiter development in a large inbred Brazilian kindred with Pendred's syndrome associated with a novel mutation in the PDS gene.
Kopp P., Arseven O.K., Sabacan L., Kotlar T., Dupuis J., Cavaliere H., Santos C.L., Jameson J.L., Medeiros-Neto G., 1999/01. The Journal of clinical endocrinology and metabolism, 84 (1) pp. 336-341. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_17C81B5354F7]
 
Resistance to TSH
Kopp P, 1999. pp. 111-144 dans Jameson JL (eds.) Hormone Resistance, Humana Press.
[serval:BIB_B394352555FF]
1998
 
A novel aminoterminal mutation in the KAL-1 gene in a large pedigree with X-linked Kallmann syndrome.
Gu W.X., Colquhoun-Kerr J.S., Kopp P., Bode H.H., Jameson J.L., 1998/09. Molecular genetics and metabolism, 65 (1) pp. 59-61. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_22A4268F92B4]
 
Autosomal recessive deficiency of combined pituitary hormones (except ACTH) in a consanguineous Brazilian kindred.
Nogueira C.R., Leite C.C., Chedid E.P., Liberman B., Pimentel-Filho F.R., Kopp P., Medeiros-Neto G.A., 1998/06. Journal of endocrinological investigation, 21 (6) pp. 386-391. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_326857B462AC]
 
Resveratrol, a phytoestrogen found in red wine. A possible explanation for the conundrum of the 'French paradox'?
Kopp P., 1998/06. European journal of endocrinology, 138 (6) pp. 619-620. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6AF75C49E1D2]
 
Surprising news: a putative sulfate transporter is defective in Pendred's syndrome.
Rutishauser J., Kopp P., 1998/06. European journal of endocrinology, 138 (6) pp. 623-624. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_14D79500D47A]
 
The thyroid hormone receptor variant alpha2 is a weak antagonist because it is deficient in interactions with nuclear receptor corepressors.
Tagami T., Kopp P., Johnson W., Arseven O.K., Jameson J.L., 1998/05. Endocrinology, 139 (5) pp. 2535-2544. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7003844D9016]
 
Thyroid disorders
Kopp P, Jameson JL, 1998. pp. 459-473 dans Jameson JL (eds.) Principles of Molecular Medicine, Humana Press.
[serval:BIB_035989C55D63]
 
Transmission of human genetic disease
Kopp P, Jameson JL, 1998. pp. 43-63 dans Jameson JL (eds.) Principles of Molecular Medicine, Humana Press.
[serval:BIB_869A4C5AAC84]
1997
 
Congenital nonautoimmune hyperthyroidism in a nonidentical twin caused by a sporadic germline mutation in the thyrotropin receptor gene.
Kopp P., Jameson J.L., Roe T.F., 1997/10. Thyroid, 7 (5) pp. 765-770. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_ABB22B24B6F0]
 
Congenital hyperthyroidism caused by a solitary toxic adenoma harboring a novel somatic mutation (serine281-->isoleucine) in the extracellular domain of the thyrotropin receptor.
Kopp P., Muirhead S., Jourdain N., Gu W.X., Jameson J.L., Rodd C., 1997/09/15. The Journal of clinical investigation, 100 (6) pp. 1634-1639. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_323063773B5C]
 
A long-sought needle in the haystack: the multiple endocrine neoplasia type 1 gene.
Kopp P., 1997/09. European journal of endocrinology, 137 (3) pp. 222-223. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_95C0DDF0B6FC]
 
Clonal X-inactivation analysis of human tumours using the human androgen receptor gene (HUMARA) polymorphism: a non-radioactive and semiquantitative strategy applicable to fresh and archival tissue.
Kopp P., Jaggi R., Tobler A., Borisch B., Oestreicher M., Sabacan L., Jameson J.L., Fey M.F., 1997/06. Molecular and cellular probes, 11 (3) pp. 217-228. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_03EEE7E1F022]
 
Expression of nitric oxide synthase III in human thyroid follicular cells: evidence for increased expression in hyperthyroidism.
Colin I.M., Kopp P., Zbären J., Häberli A., Grizzle W.E., Jameson J.L., 1997/06. European journal of endocrinology, 136 (6) pp. 649-655. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_32B99510D74D]
 
Key elements involved in the negative regulation of the TSH receptor: G protein-coupled receptor kinases, arrestin and inducible cAMP early repressor.
Kopp P., 1997/03. European journal of endocrinology, 136 (3) pp. 269-270. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9BC64A81B3BF]
 
X-linked adrenal hypoplasia and hypogonadotropic hypogonadism: multiple roles for the putative transcription factor DAX-1.
Kopp P., 1997/02. European journal of endocrinology, 136 (2) pp. 153-154. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_62362F162BDA]
1996
 
Sexually dimorphic transcriptional responses to gonadotropin-releasing hormone require chronic in vivo exposure to estradiol.
Colin I.M., Bauer-Dantoin A.C., Sundaresan S., Kopp P., Jameson J.L., 1996/06. Endocrinology, 137 (6) pp. 2300-2307. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5BBD87FE350D]
 
Second zinc finger mutants of thyroid hormone receptor selectively preserve DNA binding and heterodimerization but eliminate transcriptional activation.
Nagaya T., Kopp P., Kitajima K., Jameson J.L., Seo H., 1996/05/15. Biochemical and biophysical research communications, 222 (2) pp. 524-530. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8D35820C0C88]
 
Constitutive activation of the Gs alpha protein-adenylate cyclase pathway may not be sufficient to generate toxic thyroid adenomas.
Derwahl M., Hamacher C., Russo D., Broecker M., Manole D., Schatz H., Kopp P., Filetti S., 1996/05. The Journal of clinical endocrinology and metabolism, 81 (5) pp. 1898-1904. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_15C0D6ECE6F5]
 
Molekulare Defekte im Thyrotropin-Rezeptor als Ursache von Hyper- und Hypothyreose
Kopp P, 1996. LaboLife, 5 (30-33).
[serval:BIB_282433A4526C]
 
Syndrome of resistance to thyroid hormone: insights into thyroid hormone action.
Kopp P., Kitajima K., Jameson J.L., 1996/01. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine, 211 (1) pp. 49-61. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_ACA9FDF168BA]
1995
 
Thyroid hormone (T3) inhibits ciprofibrate-induced transcription of genes encoding beta-oxidation enzymes: cross talk between peroxisome proliferator and T3 signaling pathways.
Chu R., Madison L.D., Lin Y., Kopp P., Rao M.S., Jameson J.L., Reddy J.K., 1995/12/05. Proceedings of the National Academy of Sciences of the United States of America, 92 (25) pp. 11593-11597. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_39E1ED402E13]
 
The thyrotropin (TSH) receptor transmembrane domain mutation (Pro556-Leu) in the hypothyroid hyt/hyt mouse results in plasma membrane targeting but defective TSH binding.
Gu W.X., Du G.G., Kopp P., Rentoumis A., Albanese C., Kohn L.D., Madison L.D., Jameson J.L., 1995/07. Endocrinology, 136 (7) pp. 3146-3153. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_910F65680441]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University